Koers Yubo International Biotech Limited
Aandelen
YBGJ
US9883661004
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,21 USD | -77,89% | -77,89% | -30,00% |
Omzet 2022 | 0,1 0,1 | Omzet 2023 | 0,6 0,57 | Marktkapitalisatie | 35,95 mln. 33,62 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -935K | Nettowinst (verlies) 2023 | -1 mln. -935K | EV/omzet 2022 | 116.560.264 x |
Nettoschuld 2022 | 772K 722K | Nettoschuld 2023 | 386K 361K | EV/omzet 2023 | 60.084.725 x |
K/w-verhouding 2022 |
-9,36
x | K/w-verhouding 2023 |
-30,1
x | Werknemers | 18 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 6,63% |
1 dag | -77,89% | ||
1 week | -77,89% | ||
Lopende maand | -78,79% | ||
1 maand | -79,61% | ||
3 maanden | -30,00% | ||
6 maanden | -39,83% | ||
Lopend jaar | -30,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 01-01-19 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01-01-19 |
Wang Yang
BRD | Director/Board Member | 45 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 01-01-19 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01-01-19 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 01-01-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,00% | 114 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |